P800: CHARACTERIZATION OF REGULATORY T CELLS IN PATIENTS WITH MULTIPLE MYELOMA

P800: CHARACTERIZATION OF REGULATORY T CELLS IN PATIENTS WITH MULTIPLE MYELOMA

Bibliographic Details
Main Authors:	Sojeong Kim, June-Young Koh, Haerim Chung, Yeonhee Kim, Eui-Cheol Shin, Jeong Seok Lee, Jin Seok Kim, Hyunsoo Cho
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000970104.62297.ea

Similar Items

P851: ANTIBODY TARGETING OF SOLUBLE MHC-CLASS-I-RELATED MOLECULE AUGMENTS NATURAL KILLER CELL FUNCTION BY RESTORING NKG2D IN MULTIPLE MYELOMA
by: Sojeong Kim, et al.
Published: (2023-08-01)

Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma
by: Jennifer Wu, et al.
Published: (2024-01-01)

Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
by: Jihye Ha, et al.
Published: (2022-05-01)

Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin’s lymphoma
by: Yu Ri Kim, et al.
Published: (2021-03-01)

Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
by: Hyunsoo Cho, et al.
Published: (2021-04-01)

Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)
by: Ga-Young Song, et al.
Published: (2022-08-01)

Landscapes of SARS-CoV-2-reactive CD8+ T cells: heterogeneity of host immune responses against SARS-CoV-2
by: June-Young Koh, et al.
Published: (2021-04-01)

What happens to regulatory T cells in multiple myeloma
by: Huixian Chen, et al.
Published: (2023-12-01)

Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease
by: Ja Min Byun, et al.
Published: (2022-10-01)

Semi-quantitative FDG parameters predict survival in multiple myeloma patients without autologous stem cell transplantation
by: Hyunjong Lee, et al.
Published: (2023-10-01)

Cluster analysis of autoencoder-extracted FDG PET/CT features identifies multiple myeloma patients with poor prognosis
by: Hyunjong Lee, et al.
Published: (2023-05-01)

Total Occlusion of the Internal Carotid Artery by Subacute In-Stent Thrombosis and Subsequent Spontaneous Recanalization After Stent-Assisted Coil Embolization
by: Cheol Young Lee, et al.
Published: (2011-02-01)

Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation
by: Sung-Eun Lee, et al.
Published: (2019-02-01)

Evaluation of the R2‐ISS in real‐world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202)
by: Hyungwoo Cho, et al.
Published: (2024-01-01)

Expression of checkpoint molecules by regulatory T cells in multiple myeloma
by: A. A. Ostanin, et al.
Published: (2024-09-01)

Radotinib inhibits multiple myeloma cell proliferation via suppression of STAT3 signaling
by: Sook-Kyoung Heo, et al.
Published: (2022-01-01)

Radotinib inhibits multiple myeloma cell proliferation via suppression of STAT3 signaling.
by: Sook-Kyoung Heo, et al.
Published: (2022-01-01)

Cellular immunotherapy in multiple myeloma
by: Manh-Cuong Vo, et al.
Published: (2019-09-01)

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
by: Byung-Hyun Lee, et al.
Published: (2021-06-01)

Crystalline podocytopathy and tubulopathy without overt glomerular proteinuria in a patient with multiple myeloma
by: Eun Jeong Lee, et al.
Published: (2016-12-01)

Chromothripsis in Treatment Resistance in Multiple Myeloma
by: Kyoung Joo Lee, et al.
Published: (2017-09-01)

Formononetin Regulates Multiple Oncogenic Signaling Cascades and Enhances Sensitivity to Bortezomib in a Multiple Myeloma Mouse Model
by: Chulwon Kim, et al.
Published: (2019-07-01)

Dose Adjustment Helps Obtain Better Outcomes in Multiple Myeloma Patients with Bortezomib, Melphalan, and Prednisolone (VMP) Treatment
by: Su-Hee Cho, et al.
Published: (2019-05-01)

The Role of Regulatory T Cells and TH17 Cells in Multiple Myeloma
by: Walter M. T. Braga, et al.
Published: (2012-01-01)

Laser Cladding of WC/T-800 Cermet: Fabrication, Microstructure and Wear Properties
by: Kyoung-Wook Kim, et al.
Published: (2021-09-01)

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
by: Molly Went, et al.
Published: (2018-09-01)

Multiple myeloma associated with IgA lambda gammopathy and multiple myeloma oncogene 1 in a Yorkshire terrier
by: S. Kim, et al.
Published: (2018-04-01)

Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma
by: Hee Jeong Cho, et al.
Published: (2023-03-01)

Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma
by: Hee Jeong Cho, et al.
Published: (2023-07-01)

A resveratrol oligomer, hopeaphenol suppresses virulence activity of Pectobacterium atrosepticum via the modulation of the master regulator, FlhDC
by: Ji Eun Kang, et al.
Published: (2022-10-01)

Can deep learning reduce the time and effort required for manual segmentation in 3D reconstruction of MRI in rotator cuff tears?
by: Hyojune Kim, et al.
Published: (2022-01-01)

Can deep learning reduce the time and effort required for manual segmentation in 3D reconstruction of MRI in rotator cuff tears?
by: Hyojune Kim, et al.
Published: (2022-01-01)

Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes
by: Namsoo Kim, et al.
Published: (2024-05-01)

KIR+CD8+ and NKG2A+CD8+ T cells are distinct innate-like populations in humans
by: Seong Jin Choi, et al.
Published: (2023-03-01)

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma
by: Ga-Young Song, et al.
Published: (2020-08-01)

Resveratrol Oligomers, Plant-Produced Natural Products With Anti-virulence and Plant Immune-Priming Roles
by: Ji Eun Kang, et al.
Published: (2022-05-01)

Device Management and Data Transport in IoT Networks Based on Visible Light Communication
by: Cheol-Min Kim, et al.
Published: (2018-08-01)

2,5-Dihydroxyacetophenone Induces Apoptosis of Multiple Myeloma Cells by Regulating the MAPK Activation Pathway
by: Jeong-Hyeon Ko, et al.
Published: (2017-07-01)

An Improved Phase-Shifted DPWM Method for Reducing Switching Loss and Thermal Balancing in Cascaded H-Bridge Multilevel Inverter
by: Seok-Min Kim, et al.
Published: (2020-01-01)

Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: Results of the multicenter KMMWP2201 study
by: Ji Hyun Lee, et al.
Published: (2024-06-01)